- seekingalpha.com
- Posted On 19 November 2026
MedTech poised to outperform in 2027, Leerink says as Abbott upgraded
Leerink Partners on Thursday upgraded Abbott Laboratories (ABT) to Outperform from Market Perform, citing significant gains for the MedTech sector over the next...
Source:
seekingalpha.com